key: cord-0962598-u8920k8s
authors: D’Arena, Giovanni; La Penna, Augusto; Crocamo, Antonino; Ametrano, Marcello; Di Palma, Anna; Avino, Daniela; Pietrantuono, Giuseppe; Gambardella, Michele
title: SARS-COV2 Infection in Vaccinated Patients: Look for Clinical History and Test Humoral Immunity
date: 2021-10-11
journal: Indian J Hematol Blood Transfus
DOI: 10.1007/s12288-021-01499-6
sha: 5a2cc47771f4e5bf5373f285048b7fd84519ec2c
doc_id: 962598
cord_uid: u8920k8s

nan

On August 1st, a 72 year-old man was diagnosed with SARS-CoV2-positive bilateral broncopneumonia despite full dose of mRNA anti-SARS-CoV2 vaccine was inoculated two months before (Fig. 1 ). Hypogammaglobulinemia (0,40 g/dl; IgG 449 mg/dl; IgM 18 mg/dl), lymphopenia (270/mmc) with total B-cells absence (Fig. 2) were also found. Clinical history revealed chronic obstructive respiratory disease and low grade non-Hodgkin lymphoma treated elsewhere 14 years before for massive bone marrow involvement and splenomegaly with montly cyclophosphamide, adryamicin, oncovin and anti-CD20 monoclonal antibody Rituximab for 6 cycles. One year later, he was treated with fludarabine and rituximab because of disease refractoriness (3 cycles) with the achievement of complete remission. Since then, the patient was followed in continue complete remission.

The underlying disease affecting immune system (lymphoma), the treatment given (including targeting B-cells monoclonal antibody and fludarabine), and the severe humoral immunity impairment (lymphopenia, no detectable CD20 ? B-cells, hypogammaglobulinemia) could explain the severe immunodeficient status preventing an appropriate response to vaccination. As a matter of the fact circulating anti-S antibodies were detected at very low levels (16.7 UI/ml). This case shows that accurate clinical history and lab tests addressing humoral immunity are mandatory in patients who received anti-SARS-CoV2 vaccine and were however infected [1, 2] . 

Ethical Approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent Informed consent was obtained from the patient.

CoV2 antibody response, potential predictive markers ad safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Lymphocytes immunophenotypic profile evaluated by means of flow cytometry